BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24959453)

  • 1. Subcutaneous dermatofibroma: a rare case report with review of literature.
    Kaur H; Kaur J; Gill KS; Mannan R; Arora S
    J Clin Diagn Res; 2014 Apr; 8(4):FD01-2. PubMed ID: 24959453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous atypical fibrous histiocytoma.
    Garrido-Ruiz MC; Ramos P; Enguita AB; Rodriguez Peralto JL
    Am J Dermatopathol; 2009 Jul; 31(5):499-501. PubMed ID: 19542931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep penetrating benign fibrous histiocytoma of the foot associated with throbbing pain.
    Chung J; Namkoong S; Sim JH; Lee JS; Hong SP; Kim MH; Park BC
    Ann Dermatol; 2011 Oct; 23(Suppl 2):S239-42. PubMed ID: 22148060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of matrix metalloproteinases 1, 2, 9, and 14 in dermatofibrosarcoma protuberans and common fibrous histiocytoma (dermatofibroma).
    Weinrach DM; Wang KL; Wiley EL; Laskin WB
    Arch Pathol Lab Med; 2004 Oct; 128(10):1136-41. PubMed ID: 15387709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
    Kim HJ; Lee JY; Kim SH; Seo YJ; Lee JH; Park JK; Kim MH; Cinn YW; Cho KH; Yoon TY
    Br J Dermatol; 2007 Aug; 157(2):319-24. PubMed ID: 17596171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatous changes in dermatofibrosarcoma protuberans: a potential pitfall in the diagnosis of a serious cutaneous soft tissue neoplasm.
    Kovarik CL; Hsu MY; Cockerell CJ
    J Cutan Pathol; 2004 Aug; 31(7):492-6. PubMed ID: 15239679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign fibrous histiocytoma arising from the right shoulder: Is immunohistochemical staining always required for a definitive diagnosis?
    Akbulut S; Arikanoglu Z; Basbug M
    Int J Surg Case Rep; 2012; 3(7):287-9. PubMed ID: 22516421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75.
    West KL; Cardona DM; Su Z; Puri PK
    Am J Dermatopathol; 2014 May; 36(5):414-9. PubMed ID: 24162384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microphthalmia-associated transcription factor (MiTF): Promiscuous staining patterns in fibrohistiocytic lesions is a potential pitfall.
    Mohanty SK; Sharma S; Pradhan D; Kandukuri SR; Farahani N; Barry C; Wu JM; Frishberg D; Balzer B
    Pathol Res Pract; 2018 Jun; 214(6):821-825. PubMed ID: 29773427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
    Li N; McNiff J; Hui P; Manfioletti G; Tallini G
    Am J Dermatopathol; 2004 Aug; 26(4):267-72. PubMed ID: 15249855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Benign cellular fibrous histiocytoma with erosion of the phalanx].
    Kurzen H; Hartschuh W
    Hautarzt; 2003 May; 54(5):453-6. PubMed ID: 12719866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine needle aspiration cytology of benign fibrous histiocytoma of bone: a case report.
    Bharatnur SS; Naik CN; Swethadri GK; Fernandes H; Shekhar JC; Marla NJ
    Acta Cytol; 2010; 54(1):89-91. PubMed ID: 20306998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors.
    Hanly AJ; Jordà M; Elgart GW; Badiavas E; Nassiri M; Nadji M
    Arch Pathol Lab Med; 2006 Jun; 130(6):831-4. PubMed ID: 16740036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign Fibrous Histiocytoma: An Uncommon Presentation.
    Sarkar S; Maiti M; Bhattacharyya P; Sarkar R
    J Clin Diagn Res; 2017 Jul; 11(7):ED08-ED09. PubMed ID: 28892910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiomatoid features in fibrohistiocytic sarcomas. Immunohistochemical, ultrastructural, and clinical distinction from vascular neoplasms.
    Costa MJ; McGlothlen L; Pierce M; Munn R; Vogt PJ
    Arch Pathol Lab Med; 1995 Nov; 119(11):1065-71. PubMed ID: 7487409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
    Kahn HJ; Fekete E; From L
    Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytodiagnosis of benign fibrous histiocytoma of rib and diagnostic dilemma: a case report.
    Mondal SK
    Diagn Cytopathol; 2010 Jun; 38(6):457-60. PubMed ID: 20014125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry of dermatofibromas and benign fibrous histiocytomas.
    Prieto VG; Reed JA; Shea CR
    J Cutan Pathol; 1995 Aug; 22(4):336-41. PubMed ID: 7499573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign fibrous histiocytoma of the lower lip.
    Anand N; Kaur R; Saxena S; Bhardwaj N
    J Oral Maxillofac Pathol; 2020 Feb; 24(Suppl 1):S97-S100. PubMed ID: 32189914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatofibroma and dermatofibrosarcoma protuberans: an immunohistochemical study reveals distinctive antigenic profiles.
    Hsi ED; Nickoloff BJ
    J Dermatol Sci; 1996 Jan; 11(1):1-9. PubMed ID: 8867761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.